Omalizumab and Oral Immunotherapy in IgE-Mediated Food Allergy in Children: A Systematic Review and a Meta-Analysis
<b>Background:</b> Food allergies are a growing global health concern, particularly among children, with no widely approved curative treatment beyond strict allergen avoidance. Oral immunotherapy (OIT) has emerged as a promising strategy to induce desensitization, yet its implementation...
Saved in:
| Main Authors: | Enrico Vito Buono, Giuliana Giannì, Sara Scavone, Susanna Esposito, Carlo Caffarelli |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-03-01
|
| Series: | Pharmaceuticals |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/18/3/437 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anti-IgE therapy versus allergen-specific immunotherapy for food allergy: weighing the pros and cons
by: Michael D. Kulis, et al.
Published: (2025-07-01) -
GA2LEN ANACARE consensus statement: Potential of omalizumab in food allergy management
by: Torsten Zuberbier, et al.
Published: (2024-11-01) -
Advances in omalizumab treatment for IgE-mediated food allergies
by: Siqi WANG, et al.
Published: (2025-08-01) -
Total IgE levels in patients with hematologic malignancies
by: Parisa Amjadi, Ph.D, et al.
Published: (2025-05-01) -
Predicting Tolerance to Cow’s Milk Allergy in Children Using IgE and IgG4 Peptide Binding Profiles
by: Carlos Fernández-Lozano, et al.
Published: (2025-02-01)